inverted bright field microscope  (Motic Group)

Journal: iScience

Article Title: USP18 promotes clear cell renal cell carcinoma progression by regulating the ubiquitination and stability of YBX3

doi: 10.1016/j.isci.2026.115808

Figure Lengend Snippet: USP18 deficiency inhibits the growth of ccRCC organoids (A and B) Bright-field (A, scale bars, 500 μm) and H&E (B, scale bars, 100 μm) images showing the morphology and structure of ccRCC organoids from three patient samples. (C and D) IF data show the expression of CK7 (C) and Vimentin (D) in ccRCC organoids (scale bars, 100 μm). (E) Bright-field images showing the morphology of control and USP18-deficient ccRCC organoids. “Before” indicates the bright-field image of the organoids after transfection with shNC/shUSP18 at 72 h, and “after” indicates the bright-field image of the organoids after transfection with shNC/shUSP18 at 96 h. The images taken before and after are of the same organoids at different time points in the same field of view. (F) Change in diameter (%) of control and USP18-deficient ccRCC organoids. (G) ATP assay indicating the viability of control and USP18-deficient ccRCC organoids. (H and I) Western blot data indicate the expression of USP18, YBX3, P-AKT, and P-PI3K in control and USP18-deficient ccRCC organoids. Unpaired two-tailed Student’s t test was employed for p -value calculation. Data are represented as mean ± SD.

Article Snippet: Inverted bright-field microscope , Motic , N/A.

Techniques: Expressing, Control, Transfection, ATP Assay, Western Blot, Two Tailed Test

Journal: iScience

Article Title: USP18 promotes clear cell renal cell carcinoma progression by regulating the ubiquitination and stability of YBX3

doi: 10.1016/j.isci.2026.115808

Figure Lengend Snippet: USP18 deficiency inhibits the growth of ccRCC organoids (A and B) Bright-field (A, scale bars, 500 μm) and H&E (B, scale bars, 100 μm) images showing the morphology and structure of ccRCC organoids from three patient samples. (C and D) IF data show the expression of CK7 (C) and Vimentin (D) in ccRCC organoids (scale bars, 100 μm). (E) Bright-field images showing the morphology of control and USP18-deficient ccRCC organoids. “Before” indicates the bright-field image of the organoids after transfection with shNC/shUSP18 at 72 h, and “after” indicates the bright-field image of the organoids after transfection with shNC/shUSP18 at 96 h. The images taken before and after are of the same organoids at different time points in the same field of view. (F) Change in diameter (%) of control and USP18-deficient ccRCC organoids. (G) ATP assay indicating the viability of control and USP18-deficient ccRCC organoids. (H and I) Western blot data indicate the expression of USP18, YBX3, P-AKT, and P-PI3K in control and USP18-deficient ccRCC organoids. Unpaired two-tailed Student’s t test was employed for p -value calculation. Data are represented as mean ± SD.

Article Snippet: The morphology of organoids was examined using an inverted bright-field microscope (Motic, China) equipped with a digital camera.

Techniques: Expressing, Control, Transfection, ATP Assay, Western Blot, Two Tailed Test

Journal: Chembiochem

Article Title: Droplet Microfluidics‐Assisted Fabrication of Magnetite Nanoparticle Hybrid Microgels for Facile Protein Immobilization

doi: 10.1002/cbic.202500958

Figure Lengend Snippet: Fabrication and stability of biotin‐functionalized hybrid microgels loaded with MNPs. (A) Scheme illustrating droplet microfluidics‐assisted fabrication of biotin‐functionalized, poly(acrylamide)‐based hybrid microgels with MNPs. HµGel‐XB denotes biotinylated microgel, where X indicates biotin‐PEG‐acrylamide concentration in the precursor solution in % ( w/w ). Following ultrasonic treatment, the precursor solution is injected into microfluidic channels with flow‐focusing design (as shown in the AutoCAD design). Crosslinking of water‐in‐oil (W/O) emulsion droplets occurs via UV irradiation within the outflow tubing. (B) MNP stability in the precursor solution over time demonstrated by bright‐field microscopy images of purified microgels containing 1% ( w/w ) MNP and 2.5% biotin (HµGel‐2.5B) after 1.5 and 3.5 h of experimentation, respectively. Insets show uniform distribution of MNPs within the microgels and reveal consistent MNP loading during microfluidic processing over time. All scale bars denote 150 μm.

Article Snippet: Droplet formation was monitored through a high‐speed camera (Miro C110, Vision Research Inc., Wayne, NJ, USA) coupled to an inverted bright‐field microscope (10× objective lens, air, Axio Vert.A1, Carl Zeiss, Oberkochen, Germany).

Techniques: Concentration Assay, Injection, Emulsion, Irradiation, Microscopy, Purification

Journal: Chembiochem

Article Title: Droplet Microfluidics‐Assisted Fabrication of Magnetite Nanoparticle Hybrid Microgels for Facile Protein Immobilization

doi: 10.1002/cbic.202500958

Figure Lengend Snippet: Immobilization of sfGFP‐Mad10trunc‐His fusion protein on MNPs embedded inside pAAm‐based hybrid microgels. (A) 10× and (B) 40× bright‐field and corresponding CLSM microscopy images showing the selective binding of sfGFP‐Mad10trunc‐His to MNPs within HµGel‐1.25B after 3 days of incubation. All scale bars denote 150 µm.

Article Snippet: Droplet formation was monitored through a high‐speed camera (Miro C110, Vision Research Inc., Wayne, NJ, USA) coupled to an inverted bright‐field microscope (10× objective lens, air, Axio Vert.A1, Carl Zeiss, Oberkochen, Germany).

Techniques: Microscopy, Binding Assay, Incubation